European Coagulation Diagnostics Markets

Published by: Frost & Sullivan

Published: Aug. 17, 2007 - 85 Pages

Table of Contents

1. Executive Summary

1. Executive Summary

1. Executive Summary

2. Glossary of Terms and Exchange Rates

1. Glossary of Terms and Exchange Rates

1. Glossary of Terms

2. Exchange Rates

3. Industry Challenges

1. Industrial Challenges for European Coagulation Diagnostics Market

1. Identification of the Challenges Facing the European Coagulation Diagnostics Market

4. Market Engineering Research for the European Coagulation Diagnostics Market

1. Forecasts for the European Coagulation Diagnostics Market

1. European Coagulation Diagnostics Market

2. Research Methodology

3. Market Segmentation

4. Market Engineering Measurements

5. Market Drivers

a. Adoption of Automated Tests for Quicker TAT

b. Physician’s Loyalty towards Lab-based Tests Maintains Growth

c. POC Tests Enable Faster Test TAT

d. POCT Elevates Patient Confidence

e. Technological Advancements and Healthcare Trends Support POC

f. POC Coagulation Tests Take the Burden Off Hospitals and Laboratories

6. Market Restraints

a. Lack of Trained Professionals Results in Poor Quality Laboratory Results

b. Budgetary Control Restrictions

c. POC Tests Conducted by Non-lab Personnel Leads to Inappropriate Quality Control

d. Ageing Population's Inability to Effectively Use POC Testing and Monitoring Products

e. Devices Perform Limited Coagulation Tests and Offer Concise Test Menus

f. Introduction of Heparin Alternatives have Made Conventional Tests Obsolete

7. Revenue Forecasts

8. Technology Trends

9. Pricing Analysis

10. End-user Analysis

11. Competitive Structure

2. Forecasts for Lab-based Coagulation Diagnostics Market

1. Market Overview

2. Market Engineering Measurements

3. Revenue Forecasts Based on Geographical Regions

4. Market Share Analysis

3. Forecasts for Point-of-Care Coagulation Diagnostics Market

1. Market Overview

2. Market Engineering Measurements

3. Revenue Forecasts Based on Geographical Regions

4. Market Share Analysis

5. Strategic Recommendations

1. Market Engineering Strategic Recommendations

1. Market Engineering Strategic Recommendations

6. Database of Key Industry Participants

1. Database of Key Industry Participants

1. List of Key Industry Participants

7. Descision Support Databases

1. Descision Support Databases

1. Decision Support Databases

List of Figures

Chapter 2

Coagulation Diagnostics Market: Exchange Rates (Europe), 2006

Chapter 3

Lab-based Coagulation Diagnostics Market: Impact of Top Industry Challenges (Europe), 2007-2013

Point-of-care Coagulation Diagnostics Market: Impact of Top Industry Challenges (Europe), 2007-2013

Chapter 4

Lab-based Coagulation Diagnostics Market: Market Drivers Ranked in Order of Impact (Europe), 2007-2013

Point-of-care Coagulation Diagnostics Market: Market Drivers Ranked in Order of Impact (Europe), 2007-2013

Lab-based Coagulation Diagnostics Market: Market Restraints Ranked in Order of Impact (Europe), 2007-2013

Point-of-care Coagulation Diagnostics Market: Market Restraints Ranked in Order of Impact (Europe), 2007-2013

Coagulation Diagnostics Market: Revenue Forecasts (Europe), 2003-2013

Lab-based Coagulation Diagnostics Market: Revenue Forecasts (Europe), 2003-2013

Point-of-care Coagulation Diagnostics Market: Revenue Forecasts (Europe), 2003-2013

Coagulation Diagnostics Market: Competitive Structure (Europe), 2006

Lab-based Coagulation Diagnostics Market: Revenue Forecasts (Germany), 2003-2013

Lab-based Coagulation Diagnostics Market: Revenue Forecasts (France), 2003-2013

Lab-based Coagulation Diagnostics Market: Revenue Forecasts (Italy), 2003-2013

Lab-based Coagulation Diagnostics Market: Revenue Forecasts (The United Kingdom), 2003-2013

Lab-based Coagulation Diagnostics Market: Revenue Forecasts (Spain), 2003-2013

Lab-based Coagulation Diagnostics Market: Revenue Forecasts (Benelux), 2003-2013

Lab-based Coagulation Diagnostics Market: Revenue Forecasts (Scandinavia), 2003-2013

Lab-based Coagulation Diagnostics Market: Market Share Analysis and Trends of Major Market Participants (Europe), 2006

Point-of-care Coagulation Diagnostics Market: Revenue Forecasts (Germany), 2003-2013 4-39

Point-of-care Coagulation Diagnostics Market: Revenue Forecasts (France), 2003-2013 4-40

Point-of-care Coagulation Diagnostics Market: Revenue Forecasts (Italy), 2003-2013 4-42

Point-of-care Coagulation Diagnostics Market: Revenue Forecasts (The United Kingdom), 2003-2013

Point-of-care Coagulation Diagnostics Market: Revenue Forecasts (Spain), 2003-2013

Point-of-care Coagulation Diagnostics Market: Revenue Forecasts (Benelux), 2003-2013

Point-of-care Coagulation Diagnostics Market: Revenue Forecasts (Scandinavia), 2003-2013

Point-of-care Coagulation Diagnostics Market: Market Share Analysis and Trends of Major Market Participants (Europe), 2006

Chapter 7

Decision Support Database: Mortality Due to Coronary Heart Disease (World), 1999-2006

Decision Support Database: Number of Registered Cardiologist (World), 1999-2006

Decision Support Database: Total Population Aged 65 Years and Above in Million (World), 1999-2006

Decision Support Database: Incidence of Myocardial Infaction (World), 1999-2006

Abstract

This Frost & Sullivan research service titled European Coagulation Diagnostics Market provides a complete analysis of key market drivers, restraints and trends in the market. It provides strategic solutions to help vendors gain an advantage in the market. The research service also discusses coagulation diagnostics options that are available with respect to laboratory and POC testing.

This analysis is available through our Drug Discovery Technologies Growth Partnership Services programme. With this programme, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:

• Laboratory-based testing (involves biochemical and clinical chemistry studies)
• Point-of-care testing (concentrates on blood clotting factor and prothrombin time INR)

Technologies

The following technologies are covered in this research:

• Activated clotting time test (ACT)
• Activated partial thromboplastin time test (APTT)
• Prothrombin time test
• Anti-thrombin test
• Partial thromboplastin time (aPTT)
• Clot retraction tests

Market Overview

Availability of Coagulation Testing Labs at Point of Sales Makes Technician Training Imperative

Manufacturers of coagulation diagnostic devices have introduced point-of-sales (POS) testing labs to ensure quick turn-around-times (TAT) and better patient care. These kits are catching on rapidly in the market, with even laboratories switching over to high-volume automated analysers to maintain patient satisfaction. This decentralizing of coagulation laboratories has compelled vendors and manufacturers to provide instrument training to the lab technicians by offering regional translations of the instrument manuals. Technicians using these products should be skilled in sample handling, collection and patient preparation. Meanwhile, market participants could provide in-house training for people using home testing devices.

"With the increase in the number of patients under anticoagulant therapy, it is vital to closely monitor the prothrombin time (PT) and the International Standardized Ratio," says the analyst of this research service. "This can be achieved by installing point of care (POC) instruments in emergency units, outpatient wards and in-patient homes for self testing." This will ease the burden on hospitals, physician offices and laboratories that lack qualified lab personnel, thereby lessening the effects of anticoagulants and other bleeding disorders.

Manufacturers to Standardise the Features of Analysers to Obtain Correlated Results from Laboratories and POC Testing Labs

Market participants will be challenged to ensure correlation of results between centralised coagulation laboratories and the POC testing labs because of the difference in the reagents and test kits and other physiological factors such as temperature and humidity. They can gradually solve this issue by employing international standardised reagents. "Manufacturers of next-generation technologies in coagulation diagnostics are striving to achieve international standards and optimise their instruments," notes the analyst. "Manufacturers and laboratory personnel should collaborate to standardize all relevant features in an analyzer to build a commercially successful coagulation instrument."

POC tests should undergo proper quality control protocols with elaborate instrument calibration and trouble shooting. An ideal coagulation analyser has to be portable and easy to use, employ small volumes of blood and standardized reagents, produce rapid results, perform all coagulation tests and incur low operational costs.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.